InvestorsHub Logo

BMR News

12/27/11 11:48 AM

#171 RE: BioSpecialist #170

Again... someone just trying to scare people out of shares with utter nonsense. Clueless.

diannedawn

12/27/11 2:26 PM

#173 RE: BioSpecialist #170

I am well aware of how options work:
"The benefit of options to the employee is the difference between the market price of the stock at the time the option is exercised and the option's strike price. If the strike price is greater than the current market price, the option is "out of the money" or "under water.""

Are you sure YOU know what EXERCISING options entails???

The ones I listed were not new "grants"...
they were options EXERCISED.
They were granted long ago...and were just vested in their entirety in 2011.
"These options were granted under the Guided Therapeutics, Inc. 1995 Stock Plan as amended. Vesting for these options: "2/3rd of the shares subject to the Option vest immediately after Vesting Commencement Date, and the remaining Shares subject to the Options shall vest equally each month thereafter, being 100% vested at year end 2011.""

I'm also well aware of how PLANNED sales work...
which apparently, these all the sales you keep talking about WERE!

"( 1 )By Kuekenhof Equity Fund, LP, over which reporting person has sole dispositive and voting power. Reporting person disclaims beneficial ownership securities reported except to the extent of his pecuniary interest therein.
( 2 )The sales reported in this filing were made pursuant to the 10b5-1 plan of the reporting person."

" SEC Rule 10b5-1

SEC Rule 10b5-1 allows officers, directors and other insiders of publicly traded companies to transact in their company shares at all times, not just during open trading windows. This gives corporate insiders expanded trading opportunities. If you are a corporate officer of a public company, a 10b5-1 plan may be appropriate for you.

Corporate officers who wish to sell shares in their company often are hampered by limited trading opportunities. Trading “windows” may be closed when material nonpublic information exists and trading could potentially violate insider-trading laws. SEC rule 10b5-1, which became effective October 23, 2000, offers an opportunity for issuers and their officers and directors to structure trading programs without running afoul of the insider trading prohibitions. It permits corporate insiders to execute securities transactions in many situations where previously they might not have, out of concern over potential insider trading liability. Importantly, SEC Regulation 10b5-1 allows greater opportunity for corporate insiders to sell their shares.

Trading plans can vary in terms of complexity (see examples). However, every plan must expressly specify the amount, price and date of the purchase or sale or provide a written formula or algorithm for determining amounts, prices and dates. Additionally, the individual entering into the plan must do so at a time when he/she is unaware of material, non-public information."